Internal Medicine, Endocrinology, Diabetes, & Metabolism · Burlington, MA
NPI
1467893826
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
41 Mall Road
Burlington, MA, 01805
Phone (781) 744-2088
Groups this clinician bills Medicare through
Medicare paid, 2024
$137K
5,295 services
Medicare patients, 2024
425
Average age 72
Drug cost, 2024
$5.7M
11,600 prescriptions
Company payments, 2025
$312
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ameya Hodarkar was code 80053 (clinical chemistry), 699 times for 384 patients. In total Ameya Hodarkar billed 5,295 services in 38 codes, and Medicare paid $137K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 80053 Clinical Chemistry | Office | 699 | 384 | $10.34 | $7,225 |
| 99214 Office E&M - Established | Office | 651 | 330 | $92.25 | $60K |
| 36415 Venipuncture Blood Collection | Office | 592 | 349 | $8.65 | $5,121 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 592 | 308 | $12.76 | $7,554 |
| 83036 Blood Count | Office | 445 | 220 | $9.52 | $4,236 |
| 84443 Clinical Chemistry | Office | 331 | 197 | $16.46 | $5,448 |
| 84439 Clinical Chemistry | Office | 324 | 197 | $8.84 | $2,864 |
| 82306 Clinical Chemistry | Office | 224 | 140 | $29.01 | $6,498 |
| 83970 Clinical Chemistry | Office | 216 | 137 | $40.45 | $8,737 |
| 82570 Clinical Chemistry | Office | 196 | 143 | $5.08 | $996 |
| 82043 Clinical Chemistry | Office | 196 | 143 | $5.66 | $1,109 |
| 83721 Clinical Chemistry | Office | 157 | 144 | $10.29 | $1,616 |
| 80061 Clinical Chemistry | Office | 157 | 144 | $13.12 | $2,060 |
| 95251 Test - Miscellaneous | Office | 81 | 41 | $26.15 | $2,118 |
| 99204 Office E&M - New | Office | 70 | 70 | $102.75 | $7,193 |
By year: 2022 $105K for 4,029 services; 2023 $122K for 4,518 services; 2024 $137K for 5,295 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80053 Clinical Chemistry | 699 | 384 | $10.34 | $7,225 |
| 36415 Venipuncture Blood Collection | 592 | 349 | $8.65 | $5,121 |
| 83036 Blood Count | 445 | 220 | $9.52 | $4,236 |
| 84443 Clinical Chemistry | 331 | 197 | $16.46 | $5,448 |
| 84439 Clinical Chemistry | 324 | 197 | $8.84 | $2,864 |
| 82306 Clinical Chemistry | 224 | 140 | $29.01 | $6,498 |
| 83970 Clinical Chemistry | 216 | 137 | $40.45 | $8,737 |
| 82570 Clinical Chemistry | 196 | 143 | $5.08 | $996 |
| 82043 Clinical Chemistry | 196 | 143 | $5.66 | $1,109 |
| 83721 Clinical Chemistry | 157 | 144 | $10.29 | $1,616 |
Medicare prescription drug claims, 2024
In 2024, the drug Ameya Hodarkar prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,197 prescriptions and refills. In total Ameya Hodarkar wrote 11,600 Medicare prescriptions that cost $5.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,197 | 2,953 | 286 | $14K |
| Metformin Hcl Er Metformin Hcl | 1,116 | 2,787 | 305 | $14K |
| Jardiance Empagliflozin | 1,069 | 1,934 | 239 | $1.1M |
| Ozempic Semaglutide | 554 | 830 | 137 | $786K |
| Mounjaro Tirzepatide | 507 | 653 | 108 | $693K |
| Atorvastatin Calcium Generic | 501 | 1,265 | 127 | $5,329 |
| Trulicity Dulaglutide | 485 | 707 | 109 | $681K |
| Glipizide Generic | 459 | 1,052 | 116 | $4,077 |
| Glipizide Er Glipizide | 393 | 1,049 | 118 | $6,863 |
| Rosuvastatin Calcium Generic | 373 | 920 | 114 | $7,192 |
| Metformin Hcl Generic | 339 | 806 | 83 | $3,568 |
| Soliqua 100-33 Insulin Glargine/Lixisenatide | 310 | 645 | 78 | $343K |
| Glimepiride Generic | 277 | 584 | 70 | $3,301 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 265 | 663 | 98 | $45K |
| Pioglitazone Hcl Generic | 232 | 536 | 62 | $2,741 |
Brand drugs: 4,675 claims; generic drugs: 6,365 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ameya Hodarkar $312 ($312 in general payments such as food, travel and fees) from 3 companies. The largest payer was Amgen Inc. with $172.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.